LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”
MANAGEMENT OF PSVT: UPDATE FROM ACC25
Best Practices in Contract Negotiation: Knowing Your Worth as an MS Specialist
From PCP to Nephrologist & Supportive Patient Education to Achieve Continuity of Care and Adherence to Optimal Treatment Strategies in IgA Nephropathy
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
ATTRv-PN: Advances in Understanding and Managing Amyloid Disease with Peripheral Neuropathy
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
Unmet Needs in the Management of Atrial Fibrillation (AF)
